Clinical trials
Arteriovenous Malformations trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 2 |
| Beijing Tiantan Hospital | 2 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Chengdu University of Traditional Chinese Medicine | 1 |
| Hospices Civils de Lyon | 1 |
| Kaneka Corporation | 1 |
| Karolinska University Hospital | 1 |
| Mayo Clinic | 1 |
| Medtronic Neurovascular Clinical Affairs | 1 |
| Mercy Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arteriovenous Malformations | 23 |
| Vascular Malformations | 5 |
| Aneurysm | 4 |
| Arteriovenous Fistula | 3 |
| Vascular Diseases | 3 |
| Brain Neoplasms | 2 |
| Cardiovascular Abnormalities | 2 |
| Cardiovascular Diseases | 2 |
| Congenital Abnormalities | 2 |
| Intracranial Aneurysm | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.